Pharmaceuticals & Therapeutics

A first-in-class immunotherapy, UNLOXCYT™, offers a new lifeline for patients with advanced skin cancer, made accessible through a key national partnership.

The deal combines Apollo Care's tech platform with eStrat's copay expertise, aiming to streamline drug access and boost pharma's bottom line.

A landmark Nature Medicine publication for OrsoBio's TLC-2716 offers new hope for millions suffering from severe lipid and liver disorders.

In a strategic move to enhance domestic drug production, Agno Pharma has acquired a key Oregon manufacturing site, signaling major industry consolidation.

The pet nutrition giant previews a breakthrough feline diabetes diet, home care kits, and a fresh food line, signaling a strategic shift in pet healthcare.

With a new $16.5M loan, Ocular Science is poised to expand its role in compounded eye medications, meeting the needs of an aging population.

Backed by Canada's life sciences engine adMare, new biotech firm Ocythera is advancing a unique non-retinoid therapy for debilitating bone disorders.

The beauty industry is surging, but the focus is shifting from superficial glamour to inner wellness. Discover the rise of ingestible supplements.

New England Donor Services celebrates a record year with innovative tech, but looming federal policy changes threaten the entire organ donation system.

InterAx's AI platform and Alveus's R&D expertise combine in a new partnership to develop a next-gen obesity drug with durable results and better tolerability.

A sudden collapse led to a rare cancer diagnosis for a NJ teen. His story of recovery highlights a therapy that targets tumors while sparing young minds.

The Korean biopharma giant is leveraging its biosimilar success to fund a major push into cutting-edge cancer therapies and advanced drug platforms.

A new synthetic bone graft powered by NanoLift™ technology promises to accelerate healing and improve outcomes for orthopedic and spinal surgery patients.

Reimbursements are falling and costs are rising, but top allergy practices are boosting revenue by 22%. A new report reveals their data-driven secrets.

Nordstrom and SkinSpirit are opening their fourth in-store clinic, blending medical aesthetics with luxury retail and making Botox as accessible as lipstick.

Eagle Pharmaceuticals divests its unique post-op nausea drug to France's LXO Group, signaling a strategic pivot to oncology and critical care.

The acquisition of NorCal Vein Specialists signals a shift to integrated care, reflecting a broader trend of consolidation in specialty medicine.

A new celebrity-backed eye drop promises freedom from reading glasses. We look at the science, the competition, and what it means for 128M Americans.

With its lead cancer therapy pelareorep showing promise, Oncolytics hires veteran execs to navigate the final hurdles of clinical trials and regulatory approval.

With major funding and a seasoned CEO, Caldera Therapeutics is advancing a first-in-class bispecific antibody into the clinic for inflammatory bowel disease.